P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Sky (Low-Risk) is a relatively harmless condition. The biggest risk for Sky is overtreatment. Within Sky, the most favorable subtype of all (Low-Sky) is defined by all the usual Sky criteria of Gleason 3+3=6, PSA less than 10 and minimal or no palpable disease on DRE. In addition, to qualify as Low-Sky, the PSA density must be less than 0.15, there can be no more than two biopsy cores containing cancer and no single core can be more than 50 percent involved. Men in Low-Sky have the best chance for staying on surveillance long term without requiring treatment. At the other end of the spectrum (within Sky) is High-Sky which is defined by all the usual Sky criteria but with one or more of the following: palpable disease, a PSA density over 0.15 or more than 50% of the biopsy cores containing cancer. These men are at somewhat greater risk for disease progression, i.e., the eventual need to go off active surveillance and undergo treatment. Basic-Sky falls between the Low and High subtypes. As would be expected, the risk for men with Basic-Sky to require future treatment is intermediate between Low and High.
Various testosterone inactivating pharmaceuticals (TIP) are used to treat prostate cancer. This post addresses Casodex (Bicalutamide) as a stand-alone therapy with the goal of reducing side effects commonly associated with …
For decades the random 12-core biopsy has been the mainstay for diagnosing prostate cancer. Unfortunately, there is a slew of problems that comes with random biopsy, including misdiagnosis, infection, and …
Listen: https://soundcloud.com/prostate-oncology/six-not-a-bad-score “There’s rapid progress ongoing in the prostate cancer world and new treatments are being developed all the time. One of the major advantages of active surveillance is postponing …
Listen: https://soundcloud.com/prostate-oncology/just-cut-it-out “I’m talking about comparing the results from the best surgeons with the results from the best radiation therapists. And when you make that comparison, these results from surgery …
You’ve just been diagnosed with prostate cancer. Fear, confusion and uncertainty set in. You feel healthy, you aren’t in pain, you have no symptoms, and yet you have cancer? How …
Listen: https://soundcloud.com/prostate-oncology/pp-e0011-060419 “[Patients] do need to know that you don’t need to just rush to surgery, that you have time, you have time to make your decision…. even in the …
Listen to the episode: https://soundcloud.com/prostate-oncology/assemble-your-optimal-treatment-team “Patients need to be bold…Your quality of life and your longevity are at stake and making optimal treatment decisions is totally essential.”- Dr. Scholz Surgeons …
MARINA DEL REY, Calif., May 6, 2019 /PRNewswire/ — PROSTATE PROS is a new monthly podcast hosted by prostate cancer specialist and author Mark Scholz, MD. Beginning June 03, 2019, …
BY MARK SCHOLZ, MD Selecting treatment for prostate cancer is complex. Start by taking the Staging Quiz (keytopc.com). This is the first-step to understanding proper management. Once you know your …
BY MARK SCHOLZ,MD A Cancer that Can be Watched If someone tells you your cancer can be watched instead of treated, your initial reaction might be that they have no …